<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>Schizophrenia Drug Views - Medical Information Health Drugs Conditions Pharmacy Pills</title>
<description>schizophrenia, dementia, antidepressant, psychiatric, Drug Views, drugs, Medical, Information, Health, Drugs, Conditions, Pharmacy, Pills</description>
<link>http://www.drugviews.com/articles.php</link>
<language>en-us</language>
<generator>Ateom.com - Website Power Tools</generator>

<item>
<title>NAMI provides new dimension to Hearts &amp; Minds initiative</title>
<description><![CDATA[The National Alliance on Mental Illness is providing a new dimension to its Hearts & Minds initiative, an educational program that promotes "mind and body" <A HREF='http://www.medicare-california.com/'>health</A> practices for individuals who live with <A HREF='http://www.lorazepam-antianxiety.info/'>mental</A> illness.]]></description>
<pubDate>Thu, 02 Sep 2010 05:38:17 -0400</pubDate>
<link>http://www.drugviews.com/articles.php?t=NAMI-provides-new-dimension-to-Hearts-Minds-initiative</link>
</item>

<item>
<title>Latest achievements in brain research and treatment for mental disorders</title>
<description><![CDATA[Mental disorders, such as depression, anxiety disorders, addiction and schizophrenia are the core challenge of most <A HREF='http://www.drugstorecare.com/'>health</A> <A HREF='http://www.drugstorecare.com/'>care</A> systems around the world. In the EU alone, each year 27% of the total adult population - this corresponds to 83 Million citizens - suffer from mental disorders. Depression alone affects almost 20 million ranking in the EU as the most disabling <A HREF='http://www.zoloft-prescription.com/'>disorder</A> of all ]]></description>
<pubDate>Mon, 30 Aug 2010 07:02:44 -0400</pubDate>
<link>http://www.drugviews.com/articles.php?t=Latest-achievements-in-brain-research-and-treatment-for-mental-disorders</link>
</item>

<item>
<title>23rd ECNP Press conference on impact of circadian rhythms on human brain</title>
<description><![CDATA[All humans are synchronised to the rhythmic light-dark changes that occur on a daily basis. Rhythms in physiological and biochemical processes and behavioural patterns persist in the absence of <A HREF='http://www.healthyrecipes4all.com/'>all</A> external 24-hour signals from the physical environment, with a period that is close to 24 hours]]></description>
<pubDate>Mon, 30 Aug 2010 06:09:00 -0400</pubDate>
<link>http://www.drugviews.com/articles.php?t=23rd-ECNP-Press-conference-on-impact-of-circadian-rhythms-on-human-brain</link>
</item>

<item>
<title>23rd ECNP Congress press conference</title>
<description><![CDATA[The incidence of psychotic <A HREF='http://www.planum-temazepam.com/'>disorders</A> varies greatly across places and demographic groups, as do <A HREF='http://www.rx-store-online.com/'>symptoms</A>, course, and <A HREF='http://www.birthcontrol-drugs.com/'>treatment</A> response across individuals. High <A HREF='http://www.cursul.eu/'>rates</A> of schizophrenia in large cities, and among immigrants, cannabis users, and traumatised individuals reflect the causal influence of environmental exposures. This, in <A HREF='http://www.drugs-to-go.com/'>combination</A> with progress in the area of molecular genetics, has generated interest in <A HREF='http://www.superdiscountprescriptions.com/'>more</A> complicated <A HREF='http://www.modelsromania.com/'>models</A> of schizophrenia aetiology ]]></description>
<pubDate>Mon, 30 Aug 2010 05:52:43 -0400</pubDate>
<link>http://www.drugviews.com/articles.php?t=23rd-ECNP-Congress-press-conference</link>
</item>

<item>
<title>Forest Laboratories reveals top-line results from cariprazine Phase II clinical trial for bipolar depression</title>
<description><![CDATA[Forest Laboratories, Inc. and Gedeon Richter Plc. today announced preliminary top-line results from an 8-week Phase II clinical trial of the novel, investigational antipsychotic agent cariprazine for the treatment of bipolar <A HREF='http://www.zoloft-prescription.com/'>depression</A>. Cariprazine is currently undergoing Phase III trials for separate indications of schizophrenia and bipolar mania.]]></description>
<pubDate>Mon, 30 Aug 2010 04:31:00 -0400</pubDate>
<link>http://www.drugviews.com/articles.php?t=Forest-Laboratories-reveals-top-line-results-from-cariprazine-Phase-II-clinical-trial-for-bipolar-depression</link>
</item>

<item>
<title>An overview of Schizophrenia and psychotic disorders</title>
<description><![CDATA[Schizophrenia and related psychotic disorders are a chronic and often disabling condition. Despite modern treatment techniques they still <A HREF='http://www.clicknowrx.com/'>present</A> an enormous burden to the patients and their relatives and <A HREF='http://www.takedrug.com/'>take</A> a serious toll in terms of human suffering and societal expenditure.]]></description>
<pubDate>Mon, 30 Aug 2010 03:04:00 -0400</pubDate>
<link>http://www.drugviews.com/articles.php?t=An-overview-of-Schizophrenia-and-psychotic-disorders</link>
</item>

<item>
<title>23rd European College of Neuropsychopharmacology Congress to be held 28 Aug - 1 Sep 2010 in Amsterdam</title>
<description><![CDATA[Mental disorders, such as depression, <A HREF='http://www.order-rx-drugs.com/'>anxiety</A> disorders, addiction and schizophrenia are the core challenge of most <A HREF='http://www.onlinehealthdirectory.com/'>health</A> care systems around the world. In the EU alone, each year 27% of the total adult population - this corresponds to 83 Million citizens - suffer from mental disorders. Depression alone affects almost 20 million ranking in the EU as the most disabling disorder of all ]]></description>
<pubDate>Thu, 26 Aug 2010 08:51:18 -0400</pubDate>
<link>http://www.drugviews.com/articles.php?t=23rd-European-College-of-Neuropsychopharmacology-Congress-to-be-held-28-Aug-1-Sep-2010-in-Amsterdam</link>
</item>

<item>
<title>Neuralstem files IND with FDA for spinal cord stem cell Phase I clinical trial for chronic spinal cord injury</title>
<description><![CDATA[Neuralstem, Inc. announced that it has filed an Investigational New Drug (IND) application with the United States Food and Drug Administration (FDA) to begin a Phase I safety clinical trial for chronic spinal cord injury with its spinal cord stem cells. This multicenter Phase I safety trial will enroll a total of 16 long-term, or chronic, spinal cord injury patients, with an American Spinal ]]></description>
<pubDate>Thu, 26 Aug 2010 04:25:49 -0400</pubDate>
<link>http://www.drugviews.com/articles.php?t=Neuralstem-files-IND-with-FDA-for-spinal-cord-stem-cell-Phase-I-clinical-trial-for-chronic-spinal-cord-injury</link>
</item>

<item>
<title>SureGene collaborates with Medco Health Solutions to conduct REST study</title>
<description><![CDATA[SureGene, LLC and the Medco Research Institute, LLC, a wholly-owned subsidiary of Medco Health Solutions, Inc., today announced that they have entered into a novel investigative research collaboration to evaluate whether variation in genetic biomarkers previously identified by SureGene can help predict <A HREF='http://www.fioricet-rx.com/'>drug</A> response for widely <A HREF='http://www.prescribedrx.com/'>prescribed</A> antipsychotic drugs in patients with serious mental illness.]]></description>
<pubDate>Wed, 25 Aug 2010 02:45:00 -0400</pubDate>
<link>http://www.drugviews.com/articles.php?t=SureGene-collaborates-with-Medco-Health-Solutions-to-conduct-REST-study</link>
</item>

<item>
<title>NARSAD announces 2010 Independent Investigator grants for innovative researchers</title>
<description><![CDATA[NARSAD announced its 2010 Independent Investigator grants totaling in excess of $4.1 million, which will support 42 innovative researchers at the leading edge of discovery within neuroscience and psychiatry. Since 1987 NARSAD has awarded <A HREF='http://www.morerx.info/'>more</A> than $261.6 million in 3,832 grants to 3,132 scientists around the <A HREF='http://www.the-world-pharmacy.com/'>world</A>.]]></description>
<pubDate>Tue, 24 Aug 2010 03:02:00 -0400</pubDate>
<link>http://www.drugviews.com/articles.php?t=NARSAD-announces-2010-Independent-Investigator-grants-for-innovative-researchers</link>
</item>

<item>
<title>Deficiencies in DNA loop formation can cause multiple diseases: Research</title>
<description><![CDATA[The genes that are responsible for maintaining each cell type form DNA loops that <A HREF='http://www.onlinehealthdirectory.com/'>link</A> <A HREF='http://www.stirx.net/'>control</A> elements for these genes. This surprising genome structure is generated and reinforced by two essential protein complexes that bridge the loops and contribute to proper gene regulation.]]></description>
<pubDate>Thu, 19 Aug 2010 03:17:14 -0400</pubDate>
<link>http://www.drugviews.com/articles.php?t=Deficiencies-in-DNA-loop-formation-can-cause-multiple-diseases-Research</link>
</item>

<item>
<title>Maternal stress contribute to an elevated risk for depression in offspring: Research</title>
<description><![CDATA[For more than a century, clinical investigators have focused on early life as a source of adult psychopathology. Although the hypothesized mechanisms have evolved, a central notion remains: early life is a period of unique sensitivity during which experience confers enduring effects.]]></description>
<pubDate>Thu, 19 Aug 2010 02:58:00 -0400</pubDate>
<link>http://www.drugviews.com/articles.php?t=Maternal-stress-contribute-to-an-elevated-risk-for-depression-in-offspring-Research</link>
</item>

<item>
<title>Maternal stress associated with increased risk of schizophrenia in male offspring</title>
<description><![CDATA[For more than a century, clinical investigators have focused on early life as a source of adult psychopathology. Although the hypothesized mechanisms have evolved, a central notion remains: early life is a period of unique sensitivity during which experience confers enduring <A HREF='http://www.pills-store-online.com/'>effects</A>.]]></description>
<pubDate>Wed, 18 Aug 2010 08:33:41 -0400</pubDate>
<link>http://www.drugviews.com/articles.php?t=Maternal-stress-associated-with-increased-risk-of-schizophrenia-in-male-offspring</link>
</item>

<item>
<title>NIH awards Brain Plasticity $3.65M to improve cognitive function in people with schizophrenia</title>
<description><![CDATA[<A HREF='http://www.onlinehealthdirectory.com/'>Brain </A>Plasticity Inc., a new technology incubator dedicated to the discovery and development of novel technologies that harness the basic principles of brain plasticity to improve the lives of people with neurological and psychiatric disorders, was recently awarded $3.65 million dollars in two separate grants from the National Institutes of Health (NIH).]]></description>
<pubDate>Wed, 18 Aug 2010 01:21:35 -0400</pubDate>
<link>http://www.drugviews.com/articles.php?t=NIH-awards-Brain-Plasticity-3-65M-to-improve-cognitive-function-in-people-with-schizophrenia</link>
</item>

<item>
<title>Brain stimulation may improve thinking in people with schizophrenia</title>
<description><![CDATA[Mild electrical stimulation to the <A HREF='http://www.ultramrx.com/'>brain</A> could improve thinking and <A HREF='http://www.freebonusrx.com/'>reduce</A> auditory hallucinations in people with schizophrenia and schizo-affective <A HREF='http://www.zoloft-prescription.com/'>disorder</A>, researchers from the University of New South Wales (UNSW) have found.]]></description>
<pubDate>Tue, 17 Aug 2010 22:37:00 -0400</pubDate>
<link>http://www.drugviews.com/articles.php?t=Brain-stimulation-may-improve-thinking-in-people-with-schizophrenia</link>
</item>

<item>
<title>Depressive Cognition Scale questions can detect cognitive symptoms of early depression</title>
<description><![CDATA[A diagnostic test of eight short questions designed by Jaclene Zauszniewski from the Frances Payne Bolton School of Nursing at Case Western Reserve University can be used to detect <A HREF='http://www.rxpharmacy-online.com/'>depressive</A> thinking patterns that lead to clinical <A HREF='http://www.zoloft-prescription.com/'>depression</A> in women who <A HREF='http://www.drug-care.info/'>care</A> for an adult family member with a serious mental illness.]]></description>
<pubDate>Tue, 17 Aug 2010 05:56:00 -0400</pubDate>
<link>http://www.drugviews.com/articles.php?t=Depressive-Cognition-Scale-questions-can-detect-cognitive-symptoms-of-early-depression</link>
</item>

<item>
<title>Cortex second-quarter net loss decreases to $0.04 per share</title>
<description><![CDATA[Cortex Pharmaceuticals, Inc. reported a net loss applicable to common stock of approximately $2,454,000, or $0.04 <A HREF='http://www.ppmchat.com/'>per</A> share, for the quarter ended June 30, 2010, compared with a net loss applicable to common stock of approximately $2,778,000, or $0.06 <A HREF='http://www.ppmchat.com/'>per</A> share, for the corresponding prior year period.]]></description>
<pubDate>Mon, 16 Aug 2010 09:46:25 -0400</pubDate>
<link>http://www.drugviews.com/articles.php?t=Cortex-second-quarter-net-loss-decreases-to-0-04-per-share</link>
</item>

<item>
<title>ARYx secures bridge financing, reports decrease in net loss to $3.6M for second-quarter 2010</title>
<description><![CDATA[ARYx Therapeutics, Inc. today announced that it has secured bridge financing to allow ARYx <A HREF='http://www.druganytime.com/'>time</A> and resources to potentially complete a <A HREF='http://www.buy-ultracet-online.com/'>transaction</A> that could create significant <A HREF='http://www.rxdiscountplus.com/'>value</A> for stockholders. ARYx also released its financial results for the second quarter of 2010.]]></description>
<pubDate>Mon, 16 Aug 2010 08:43:59 -0400</pubDate>
<link>http://www.drugviews.com/articles.php?t=ARYx-secures-bridge-financing-reports-decrease-in-net-loss-to-3-6M-for-second-quarter-2010</link>
</item>

<item>
<title>Recent research on schizophrenia published in journal Current Directions in Psychological Science</title>
<description><![CDATA[It has been nearly a century since the term "schizophrenia" was first used to describe what was then considered a hopeless and incurable <A HREF='http://www.zoloft-prescription.com/'>disorder</A> of thought and emotion. Schizophrenia is still baffling to both scientists and the <A HREF='http://www.buy-fioricet-generic.com/'>general</A> public, but it is no longer considered hopeless. Significant advances have been made on several fronts in fathoming and combating this debilitating mental illness-from genetics to ]]></description>
<pubDate>Mon, 16 Aug 2010 07:42:00 -0400</pubDate>
<link>http://www.drugviews.com/articles.php?t=Recent-research-on-schizophrenia-published-in-journal-Current-Directions-in-Psychological-Science</link>
</item>

<item>
<title>Survey: Majority of U.S. pharmaceutical companies develop drugs for mental illness</title>
<description><![CDATA[Pharmaceutical research and biotechnology companies in New Jersey, California, New York and North Carolina are responsible for 192 of the 313 medicines in development today to <A HREF='http://www.tramadolhclbuy.com/'>treat</A> mental illnesses, a new survey shows.]]></description>
<pubDate>Mon, 16 Aug 2010 06:03:00 -0400</pubDate>
<link>http://www.drugviews.com/articles.php?t=Survey-Majority-of-U-S-pharmaceutical-companies-develop-drugs-for-mental-illness</link>
</item>

</channel>
</rss>